Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases

BACKGROUND: Assessment of platelet inhibition for aspirin therapy is important to manage patients who are at potential risk of developing thrombotic and hemorrhagic complications. OBJECTIVE: This study aimed to evaluate a new platelet assay (Anysis-aspirin), compare it with VerifyNow-aspirin in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Piao, Jinxiang, Yoo, Chaeyoung, Kim, SeonYoung, Whang, Youn-Wha, Choi, Cheol Ung, Shin, Sehyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673509/
https://www.ncbi.nlm.nih.gov/pubmed/33967038
http://dx.doi.org/10.3233/CH-211171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673509/
https://www.ncbi.nlm.nih.gov/pubmed/33967038
http://dx.doi.org/10.3233/CH-211171

Ejemplares similares